As of Q4 2024, the wholesale acquisition cost of autoimmune disease drug Remicade was 1,168 U.S. dollars, compared to 946 U.S. dollars for the biosimilar Inflectra. Biosmilars of Remicade were able to reduce costs between 19 and 59 percent. This statistic illustrates a comparison WAC of Remicade vs biosimilars in the United States.
Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q4 2024
(in U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Samsung Bioepis. (November 10, 2024). Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q4 2024 (in U.S. dollars) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Samsung Bioepis. "Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q4 2024 (in U.S. dollars)." Chart. November 10, 2024. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Samsung Bioepis. (2024). Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q4 2024 (in U.S. dollars). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Samsung Bioepis. "Comparison of The Wholesale Acquisition Cost (Wac) of Remicade Vs Biosimilars in The United States as of Q4 2024 (in U.S. Dollars)." Statista, Statista Inc., 10 Nov 2024, https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Samsung Bioepis, Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q4 2024 (in U.S. dollars) Statista, https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/ (last visited December 22, 2024)
Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of Q4 2024 (in U.S. dollars) [Graph], Samsung Bioepis, November 10, 2024. [Online]. Available: https://www.statista.com/statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
